BBNX
Beta Bionics, Inc.
NASDAQ · USHealthcareMedical - Equipment & Services
$17.82+3.07%
Price as of Jul 20, 2026
BBNX growth
Beta Bionics, Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +57.9%
- EBITDA
- +9.5%
- EBIT
- -42.0%
- EPS
- +53.3%
- Free cash flow
- -2.9%
- Operating cash flow
- +2.4%
Forward estimates
- Revenue
- +39.4%
- EBITDA
- —
- EPS
- -29.1%
Three-year CAGR
- Revenue
- +724.3%
- EBITDA
- -31.2%
- EBIT
- -58.4%
- Net income
- -33.7%
- EPS
- +79.0%
- Free cash flow
- -8.8%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.